Post-mortem and in vivo TSPO measurements of AD brains have shown greater TSPO density in later stages of AD, correlating AD-associated cognitive decline with microglial activation (Edison et al., 2018; Xu et al., 2019). The gene discussed is TSPO; the disease is Mental deterioration.